SecBot SecBot
8-K ·Filed Oct 6, 2026

CHRN

ChronoScale Holdings Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed20d 11h ago SEC0001493152-26-046010
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

The board departure is a mechanical consequence of the Ekso sale and carries no negative signal. Monitor the company's next quarterly filing for post-divestiture financials and any further board changes tied to the ongoing proxy contest.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
CHRN ▼ -24.73% at T+5d
NEUTRAL call -24.73% · α vs SPY -23.75% · entry $19.77 → $14.88
Next anchor: T+20d in 7d
Latest observation: T+12 -11.50% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
-3.74%
call -3.74% · α -3.32%
$19.03
settled 20d ago
T+5d
-24.73%
call -24.73% · α -23.75%
$14.88
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Scott Davis resigned from the board of ChronoScale Holdings Corp effective October 3, 2026, following the sale of subsidiary Ekso Bionics. The company granted him 51,626 fully vested RSUs and a $709,500 cash release payment. The departure is a routine consequence of the subsidiary sale, not a red-flag resignation.

Key Facts

  • Scott Davis resigned from the board effective October 3, 2026, in connection with the sale of Ekso Bionics completed September 30, 2026.
  • No disagreements between the company and Mr. Davis led to his resignation.
  • Mr. Davis received 51,626 fully vested RSUs on October 2, 2026.
  • Mr. Davis is entitled to a lump sum cash payment of $709,500 under a Release Agreement, payable within 30 days.
  • The Release Agreement includes a general release of claims and continuing restrictive covenants.

Financial Impact

Cash payment of $709,500 and 51,626 fully vested RSUs to departing director; immaterial relative to company size.

cashshare count

Risk Factors

  • Ongoing proxy contest (per cross-filing DEFA14A) could lead to additional board turnover or strategic shifts.
  • Post-sale revenue base will be smaller; monitor for guidance updates.

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-046010
Document: 0001493152-26-046010-index-headers.html0001493152-26-046010
Document: 0001493152-26-046010-index.html0001493152-26-046010
Document: 0001493152-26-046010.txt0001493152-26-046010
17 reports for CHRN
Performance horizon
75% Hit rate @ T+1 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+1▲ +8.77%Oct 13, 2026
Filters
Rows
Reports for CHRN — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
DEFA14A
NEUTRAL ★ 3/10
$14.97 $15.76▲ +5.28%▲ +4.94%$14.63 (−2.27%)
Oct 15, 2026
11d ago
8-K
MIXED ★ 6/10
$15.08 $14.97▼ −0.73%▼ −1.15%$14.63 (−2.98%)
Oct 15, 2026
11d ago
Press Release
MIXED ★ 6/10
$15.08 $14.97▼ −0.73%▼ −1.15%$14.63 (−2.98%)
Oct 13, 2026
14d ago
EFFECT
BEARISH ★ 5/10
$16.31 $14.88▲ +8.77%▲ +7.69%$14.63 (+10.30%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$19.77 $19.03▼ −3.74%▼ −3.32%$14.63 (−26.00%)
Oct 6, 2026
20d ago
S-3
NEUTRAL ★ 3/10
$19.77 $19.03▼ −3.74%▼ −3.32%$14.63 (−26.00%)
Oct 2, 2026
24d ago
8-K
BULLISH ★ 6/10
$18.60 $19.28▲ +3.66%▲ +3.11%$14.63 (−21.34%)
Oct 1, 2026
25d ago
Press Release
BULLISH ★ 6/10
$19.21 $18.60▼ −3.18%▼ −3.85%$14.63 (−23.84%)
Sep 25, 2026
4w ago
DEFA14A
NEUTRAL ★ 5/10
$19.82 $19.75▼ −0.33%▼ −0.14%$14.63 (−26.17%)
Sep 25, 2026
4w ago
DEF 14A
NEUTRAL ★ 4/10
$19.82 $19.75▼ −0.33%▼ −0.14%$14.63 (−26.17%)
Showing 10 of 17

US Market Status

Market Closed — Opens in 4h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026